(MENAFN- Kashmir Observer)A wreath lies on the coffin of a COVID-19 victim before his cremation in Jammu | PTI
Jammu: The spurt in coronavirus fatalities across the Union Territory, especially in Jammu division last month have been attributed to the B.1.617.2 variant of coronavirus named as Delta by the World Health Organization (WHO).
Recent epidemiological studies have suggested the role of the new SARS-CoV-2 variants for ragging second COVID wave in India including Jammu and Kashmir, an official spokesperson said. He said that the sudden increase in the number of COVID related deaths in UT of J & K especially in Jammu raised an alarm about the circulating variant of concern (B.1.617.2) in Jammu, which was proved right by the study, said Dr Shashi Sudhan Principle and Dean GMC Jammu.
As per the official spokesperson, Dr Sudhan said that the COVID positive samples are routinely sent to Indian SARS CoV-2 Consortium of Genomics (INSACOG) for genomic sequencing and analysis of circulating COVID-19 viruses and several variants have been reported in Jammu.
He also quoted the Principle GMC as saying that there was available information to suggest that the increased transmissibility and increased deaths in the month of May were linked to the variant of concern.
The official spokesperson further said that as per the recent data of Covid-19 Positives samples sent from Department of Microbiology, GMC Jammu to National Centre for Disease Control, Delhi, for genetic sequencing, 68.5% of the tested positive patients were reported to have variant of concern i.e. B.1.617.2, generally known as the double mutant and been classified as being ''of concern'' by the WHO.
''The PMC further said that the mortality rate among patients admitted in the HDU of GMC, Jammu was 62.5% in those infected with the ''variant of concern,'' with a very high number of young patients, indicating the higher public health implications of the variant,'' he added.
According to the official spokesperson, Dr. Sudhan further added that among those patients admitted 58.4% were reported to have B.1.617.2, 22.47% were reported to have B.1 mutation, 6.74% were having B.1.1 mutant, 3.37% had B.1.617.1 variant while as 1.1% had B .1.1.7 the UK variant.
''Further, she added that 2.247% of admitted patients were reported to have no mutant at all,'' he added.
Be Part of Quality Journalism
Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.
| ACT NOW |
| MONTHLY || Rs 100 || |
| || || |
| YEARLY || Rs 1000 || |
| || || |
| LIFETIME || Rs 10000 || |
| || || |
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.